Mental Health DailyResearch. Evidence. Perspective.Published research on trazodone.
Patients with chronic insomnia frequently end up on both a sleep medication and cognitive behavioral therapy for insomnia (CBT-I), and a 2026 AASM meta-analysis of 15 RCTs from Buysse et al.…
Read articleFrontotemporal dementia (FTD) is a challenging and impactful neurodegenerative disease. Recent research offers new insights into its management, particularly regarding the effectiveness of p…
Read articleTrazodone (brand name “Desyrel”) is a medication originally approved by the FDA in 1981 for the treatment of anxiety disorder and major depressive disorder. It is also commonly utilized as a…
Read articleTrazodone (Desyrel) is classified as an atypical antidepressant, functioning specifically as an SARI (serotonin antagonist and reuptake inhibitor). It is considered a second generation antid…
Read articleTrazodone (Desyrel) is a medication that is approved for the treatment of depression. It is classified as an atypical antidepressant that functions as a “SARI” (serotonin antagonist and reup…
Read articleAtypical antidepressants are unique from other classes of antidepressants based on pharmacological properties. These days, the most common antidepressants fit into one of a few categories: S…
Read articleTrazodone is an antidepressant drug that works as a serotonin antagonist and reuptake inhibitor (SARI). Although it is primarily utilized to treat major depression, Trazodone is also used to…
Read article
